Blueshift Asset Management, LLC Biogen Inc. Transaction History

Blueshift Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $246,088 - $316,259	-1,099 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $311,006 - $405,585	1,099 New	1,099 $311,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $193,413 - $213,197	-882 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $191,138 - $298,962	882 New	882 $208,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.